Tharimmune, Inc. | WebDisclosure

Basculer en Français

8295	Companies
114810	Keywords
55260	Articles
62423	Press releases

Home
Companies
Tharimmune, Inc.

BRIEF

published on 11/18/2024 at 14:05, 2 days 19 hours ago

Tharimmune partage des données prometteuses sur le TH104 lors du Liver Meeting

TH104 Essai Clinique Tharimmune Maladie Du Foie Prurit
BRIEF

published on 11/18/2024 at 14:05, 2 days 19 hours ago

Tharimmune Shares Promising TH104 Data at Liver Meeting

TH104 Clinical Trial Tharimmune Liver Disease Pruritus
PRESS RELEASE

published on 11/18/2024 at 14:00, 2 days 20 hours ago

Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease
Tharimmune, Inc. presents promising Phase 1 TH104 clinical data at The Liver Meeting® 2024, demonstrating significant correlation between blood levels and symptom relief in chronic liver disease patients

Tharimmune Inc. TH104 Chronic Pruritus Primary Biliary Cholangitis The Liver Meeting 2024
BRIEF

published on 11/13/2024 at 14:05, 7 days 19 hours ago

Tharimmune obtient un brevet européen pour une plateforme innovante de thérapie contre le cancer

Tharimmune Brevet Européen Thérapies Contre Le Cancer Administration De Médicaments Nanoparticules Biodégradables
BRIEF

published on 11/13/2024 at 14:05, 7 days 19 hours ago

Tharimmune Secures European Patent for Innovative Cancer Therapy Platform

Drug Delivery Tharimmune European Patent Cancer Therapies Biodegradable Nanoparticles
PRESS RELEASE

published on 11/13/2024 at 14:00, 7 days 20 hours ago

Tharimmune Granted European Patent for Delivery of Optimized Molecularly Targeted Therapeutics
Tharimmune, Inc. announces the European Patent Office intends to grant a patent for biodegradable polymeric nanoparticles designed to enhance therapeutic delivery in cancer therapies. The innovative platform aims to reduce side effects and improve therapy effectiveness

Patent Tharimmune Cancer Therapies Nanoparticles Therapeutic Delivery
BRIEF

published on 11/04/2024 at 15:05, 16 days 18 hours ago

Tharimmune annonce sa participation aux prochaines conférences

Biotechnologie TH104 Réunions D'investisseurs Tharimmune Participation À La Conférence
BRIEF

published on 11/04/2024 at 15:05, 16 days 18 hours ago

Tharimmune Announces Participation in Upcoming Conferences

Biotechnology TH104 Investor Meetings Tharimmune Conference Participation
PRESS RELEASE

published on 11/04/2024 at 15:00, 16 days 19 hours ago

Tharimmune Announces Upcoming Conference Presentations
Tharimmune, Inc. announces participation in 2024 Spartan Capital Investor Conference and AASLD The Liver Meeting® 2024. Details on upcoming events and key developments in biotechnology

Biotechnology Tharimmune Inc. Clinical-stage Inflammation Immunology
BRIEF

published on 10/30/2024 at 13:05, 21 days 20 hours ago

Tharimmune Secures EMA Feedback for TH104 in Chronic Pruritus

Chronic Pruritus Tharimmune PBC Treatment EMA Feedback TH104 Clinical Program

1 2 ... 5

Accesswire

Published on 11/21/2024 at 09:00, 1 hour ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 25 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 35 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 10 hours ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 11 hours ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:41, 18 minutes ago

Original-Research: 2G Energy AG (von First Berlin Equity Research GmbH): Buy
Published on 11/21/2024 at 09:01, 58 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 1 hour ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 1 hour ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 45 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 2 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 3 hours 2 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 3 hours 2 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 52 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 40 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE